Mar 06, 2026

Public workspaceProteomics Sample Preparation (Urea/trypsin digestion) - for Mammalian tissues

 Forked from Sample Preparation (Urea/trypsin digestion) for Proteomics - Mammalian Organisms
DOI
https://dx.doi.org/10.17504/protocols.io.yxmvm1qqnv3p/v1
  • Geremy Clair1,
  • Heather Olson1,
  • Ernesto Nakayasu1,
  • WEI-JUN QIAN1
  • 1Pacific Northwest National Laboratory
  • Human BioMolecular Atlas Program (HuBMAP) Method Development Community
  • Pacific Northwest National Laboratory (PNNL)
Geremy Clair
Icon indicating open access to content
QR code linking to this content
DOI: https://dx.doi.org/10.17504/protocols.io.yxmvm1qqnv3p/v1
Protocol Citation: Geremy Clair, Heather Olson, Ernesto Nakayasu, WEI-JUN QIAN 2026. Proteomics Sample Preparation (Urea/trypsin digestion) - for Mammalian tissues. protocols.io https://dx.doi.org/10.17504/protocols.io.yxmvm1qqnv3p/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: February 16, 2026
Last Modified: March 06, 2026
Protocol Integer ID: 243412
Keywords: Proteomics, Sample preparation, mass-spectrometry, LC-MS, Bottom-up, preparation of peptide sample, peptide sample, proteomic analysis, based proteomic analysis, proteins from mammalian sample, proteomic, mammalian sample, sample preparation, trypsin digestion, peptide, mass spectrometry, protein, mammalian organisms this procedure, sample, preparation, procedure, proteomics sample preparation, mammalian tissues this procedure, mammalian tissue
Funders Acknowledgements:
NIH - Biorepository for Investigation of Neonatal Diseases of Lung-Normal (BRINDL-NL)
Grant ID: U01HL122700
NIH - Biorepository for INvestigation of Diseases of the Lung (BRINDL) - Phase II
Grant ID: U01HL148861
NIH - The Human Lung BioMolecular Multi-Scale Atlas Program (HuBMAP-Lung)
Grant ID: U54HL165443
NIH - Research Center for Spatiotemporal Lung Imaging and Omics
Grant ID: U01HL148860
Disclaimer
For research purpose only
Abstract
This procedure is to be used for preparation of peptide samples from proteins from mammalian samples. The peptide samples will be used for mass spectrometry based proteomic analysis.
Materials
Chemical supplies
  1. NH4HCO3 (e.g., Thermo Scientific Catalog number 393212500), prepared in solution : 50 mM pH8 buffer
  2. Urea (e.g., in solid form from Thermo Scientific, Catalog number 036428.A3)
  3. Dithiothreitol (DTT) - (e.g., Pierce, No-Weigh Format,Catalog number A39255)
  4. Iodoacetamide (e.g., Pierce, No-Weigh Format, Catalog number A39271)
  5. 1 M CaCl2 in MilliQ water (e.g., Thermo Scientific, Catalog number L13191.0I)
  6. Sequencing grade modified Trypsin (e.g., Promega, Catalog number V5111)
  7. BCA protein assay reagents (e.g., Pierce, Catalog number 23225)
  8. HPLC-grade methanol (e.g., Thermo Scientific, Catalog number 325740025)
  9. HPLC-grade trifluoroacetic acid (TFA)(e.g., Thermo Scientific, Catalog number 393212500) at 0.1% v/v in ultrapure water
  10. A solution of HPLC-grade 95:5 H2O:Acetonitrile (ACN), 0.1% TFA (example of ACN source, Thermo Scientific Catalog number 044630.AY)
  11. A solution of 80:20 ACN:H2O, 0.1% TFA
  12. Ultrapure water (e.g. Milli-Q, Nanopure)

Non-Chemical Supplies
  1. Vortexer mixer
  2. ThermoMixer with Thermoblock for the size of tubes you are using
  3. Low-retention microcentrifuge tubes (0.6, 1.5, and/or 2.0 mL, the tube have to be low retention and tested to not leach plastic mono/polymers that would be detrimental for mass spectrometry)
  4. 15- and/or 50-mL centrifuge tubes
  5. Incubator at 37 ℃
  6. Centrifugal vacuum concentrator (e.g. ThermoSavant SpeedVac or Labconco Centrivap)
  7. Vials compatible with the LC-MS system
  8. 1 mL capacity 50- or 100-mg C18 Solid Phase Extraction (SPE) column/tube
  9. Vacuum manifold with controlled vacuum for SPE tubes
  10. Glass test tubes
  11. Pipets
  12. Pipet tips

Troubleshooting
Safety warnings
If the samples to be prepared are from human origin or may contain infectious organisms, this procedure must be performed in conditions meeting the bio-safety laboratory (BSL) requirements at your facility and adapted to the type of samples. This usually requires the use of Biosafety Cabinets (BSC's) for the procedure.
Ethics statement
The protocols.io team notes that research involving animals and humans must be conducted according to internationally-accepted standards and should always have prior approval from an Institutional Ethics Committee or Board.
Protein digestion
Use the method of your choice to extract the proteins from the samples (e.g. MPLEx procedure, sonication, tissue homogenization, etc.).
Ensure that a BCA has been performed and that you have calculated the sample volume.
Add powdered form of Urea to sample to a target concentration of 8 M (0.745 * Sample Volume = mg of Urea).
Note that the sample volume will increase to approximately: Sample Volume + (0.550*Sample Volume)
Vortex sample for 5-10 sec on highest setting or gently rotate end-over end until Urea is completely dissolved.

Prepare a 500 mM solution of Dithiothreitol (add 100 μL to 7.7 mg DTT No-Weigh tube). Add an appropriate volume of the DTT solution to obtain a 5 mM concentration in the sample.
Incubate in a thermomixer (or equivalent dry bath) at 37ºC for 1 hour, at 600-800 rpm.
Weigh out sufficient amount of iodoacetamide to have a final concentration of 400 mM (74 mg per 1 mL Nanopure water). Add an appropriate volume of iodoacetamide to obtain a 40 mM concentration in the sample.
Incubate in a thermomixer (or equivalent dry bath) at 37ºC for 1 hour, in the dark, at 600-800 rpm.
Pre-activate trypsin by incubating for 10 minutes at 37ºC.
Dilute the sample 8-fold with 50 mM NH4HCO3 to reduce the salt concentration.
Add sufficient amount of a 1M solution of CaCl2 to obtain a sample concentration of 1 mM CaCl2.
Digest sample for 3 hours with Trypsin @ 37ºC at a concentration of 1 μg trypsin/50 μg protein.
(Note: at this stage after a quick freeze of the resulting peptides in liquid nitrogen, it can be stored at –80ºC until needed for analysis.)
Sample SPE cleanup
Choose an appropriate solid phase extraction (SPE) C18 column. The capacity of each column is usually 5% of the bed weight. Therefore, a 25 mg column can hold up to 1.25 mg of digested peptides. C18 SPE cleanups are good for samples that do not contain any detergents.
Condition column with 3 mL of MeOH.
(note : Columns can withstand going to dryness between steps as long as the dry period is extended for no longer than 30 seconds. However, the columns cannot be allowed to go dry between the Methanol and 0.1% TFA steps.)
Rinse column with 2 mL acidified water (0.1% TFA)
Slowly put sample solution through the column (no faster than 1 mL/minute).
Wash column containing sample with 4 mL of 95:5 H2O:ACN, 0.1% TFA.
Allow column to go to dryness and blot “needles” below columns dry.
Put collection tubes under column, and while SPE tubes are closed off from vacuum add 1 mL of 80:20 ACN:H2O, 0.1% TFA.
Allow elution buffer to flow slowly through column until column is dry.
Remove sample from SPE vacuum chamber.

Concentrate sample in speedvac (or equivalent) to a volume of ~50-100 μL.
Perform a BCA assay on sample, following the supplier's instructions.
(Note: at this stage after a quick freeze of the sample in liquid nitrogen, it can be stored at –80ºC until needed for analysis.)
Peptide vialing
Dilute the samples in ultrapure water to the concentration of 0.1 μg of peptide per μL (or to the concentration of your choice).
(note : we typically run 5 μL at 0.1 μg/μL in the Thermo Orbitrap instruments)
Vial sample with an excess volume to ensure that the volume to be injected by the autosampler will be smaller than the volume contained in the vial
(note : we typically vial between 12 and 50 μL 0.1 μg/μL of peptides to ensure one or multiple injections of 5 μL at 0.1 μg/μL in the Thermo Orbitrap instruments).

Freeze the samples at -20 ºC until the samples are placed in the LC-autosampler.
(note: to reduce peptide degradation, the samples should be run in the 2 months following preparation)
Acknowledgements
This work was supported by the National Heart, Lung, and Blood Institute (NHLBI) Molecular Atlas of Lung Development Program Human Tissue Core (LungMAP HTC) and LungMAP BioRepository for INvestigation of Diseases of the Lung (BRINDL) through grants U01HL122700 and U01HL148861 (to GS Pryhuber), and U01HL148860 (G. Clair) and by the NIH Common Fund grant U54HL165443 (to GS Pryhuber with Co-Investigators G Clair, and C Anderton). Part of this work was performed in the Environmental Molecular Science Laboratory, a U.S. Department of Energy (DOE) national scientific user facility at Pacific Northwest National Laboratory (PNNL). Battelle operates PNNL for the DOE under contract DE-AC05-76RLO01830. The opinions expressed in this article are the authors’ own and do not reflect the view of the NIH, the Department of Health and Human Services, or the U.S. government. We are very grateful for the generosity of the donor families and honor their loss.